VCEL compared with TGTX: revenue, margins and what each company keeps, and the suppliers and customers both name

VCELVericel Corp

Mkt capRevenueRevenue

TGTXTG Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

VCELVericel Corp

TGTXTG Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only VCEL 5

—Matricel GmbHunlistedsupplier

—MediWoundunlistedsupplier

—AllCare Plus Pharmacyunlistedsupplier

—Orsini Pharmaceutical Servicesunlistedsupplier

1 more · VCEL chain ›

Shared 0

No shared counterparties.

Only TGTX 7

DTILPrecision Biosciencessupplier

MXCTMaxcytesupplier

FBIOFortress Biotechsupplier

—FUJIFILM Diosynth Biotechnologiesunlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

supplier

3 more · TGTX chain ›

VCELVericel Corp

45.66▲+11.12%· post 45.63· delayed

Mkt cap$2.3BRevenue$77MQ2 FY26Revenue$276MFY25

TGTXTG Therapeutics, Inc.

60.76▲+0.02%· post 61.67· delayed

After hoursNov 4 '26delayed

Mkt cap$9.3BRevenue$240MQ2 FY26Revenue$616MFY25

Compare

After hoursNov 4 '26delayed

VCELVericel Corp

TGTXTG Therapeutics, Inc.

45.66▲+11.12%post 45.63delayed

Price

60.76▲+0.02%post 61.67delayed

$2.3B

Mkt cap

$9.3B

Q2 FY26$77M

Revenue

$240MQ2 FY26

FY25$276M

Revenue

$616MFY25

VCEL45.66▲+11.12%vsTGTX60.76▲+0.02%After hoursNov 4 '26delayed